Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ovulation Induction With Clomiphene Citrate: to Support or Not to Support the Luteal Phase
Brief Summary: The purpose of this study is to assess the effect of luteal phase supplement (LPS) on pregnancy rate in IUI cycles stimulated with clomiphene citrate.


Options:
A: Arm Label: Menotropin/Progesterone vaginal insert; Type: EXPERIMENTAL; Interventions: Drug: Menotropin, Drug: Progesterone vaginal insert, Drug: leuprolide acetate | Arm Label: Menotropin/Progesterone in oil; Type: EXPERIMENTAL; Interventions: Drug: Menotropin, Drug: Progesterone in oil, Drug: leuprolide acetate | Arm Label: Follitropin beta/Progesterone vaginal insert; Type: ACTIVE_COMPARATOR; Interventions: Drug: Progesterone vaginal insert, Drug: Follitropin beta, Drug: leuprolide acetate | Arm Label: Follitropin beta/Progesterone in oil; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin beta, Drug: Progesterone in oil, Drug: leuprolide acetate | Intervention Type: DRUG; Name: Menotropin; Assigned to Arm(s): Menotropin/Progesterone in oil, Menotropin/Progesterone vaginal insert | Intervention Type: DRUG; Name: Progesterone vaginal insert; Assigned to Arm(s): Follitropin beta/Progesterone vaginal insert, Menotropin/Progesterone vaginal insert | Intervention Type: DRUG; Name: Follitropin beta; Assigned to Arm(s): Follitropin beta/Progesterone in oil, Follitropin beta/Progesterone vaginal insert | Intervention Type: DRUG; Name: Progesterone in oil; Assigned to Arm(s): Follitropin beta/Progesterone in oil, Menotropin/Progesterone in oil | Intervention Type: DRUG; Name: leuprolide acetate; Assigned to Arm(s): Follitropin beta/Progesterone in oil, Follitropin beta/Progesterone vaginal insert, Menotropin/Progesterone in oil, Menotropin/Progesterone vaginal insert
B: Arm Label: Endometrial injury group; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial injury | Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Procedure: Control group | Intervention Type: PROCEDURE; Name: Endometrial injury; Assigned to Arm(s): Endometrial injury group | Intervention Type: PROCEDURE; Name: Control group; Assigned to Arm(s): Control group
C: Arm Label: hCG in the late follicular phase + luteal phase; Type: EXPERIMENTAL; Interventions: Drug: hCG(r-hCG, Ovitrelle, Merck-Serono, Hellerup, Denmark) in the late follicular phase + luteal phase | Arm Label: hCG in the follicular phase + luteal phase; Type: EXPERIMENTAL; Interventions: Drug: hCG(r-hCG, Ovitrelle,Merck-Serono, Hellerup, Denmark) in the follicular phase + luteal phase | Arm Label: LH in the luteal phase; Type: EXPERIMENTAL; Interventions: Drug: LH(r-LH,Luveris, Merck-Serono, Hellerup, Denmark) in the luteal phase | Arm Label: vaginal progesterone and estradiol in the luteal phase; Type: ACTIVE_COMPARATOR; Interventions: Drug: vaginal progesterone(Crinone; Merck-Serono, Hellerup, Denmark) and estradiol(Estrofem; Novo Nordisk, Copenhagen, Denmark) in the luteal phase | Intervention Type: DRUG; Name: hCG(r-hCG, Ovitrelle, Merck-Serono, Hellerup, Denmark) in the late follicular phase + luteal phase; Assigned to Arm(s): hCG in the late follicular phase + luteal phase | Intervention Type: DRUG; Name: hCG(r-hCG, Ovitrelle,Merck-Serono, Hellerup, Denmark) in the follicular phase + luteal phase; Assigned to Arm(s): hCG in the follicular phase + luteal phase | Intervention Type: DRUG; Name: LH(r-LH,Luveris, Merck-Serono, Hellerup, Denmark) in the luteal phase; Assigned to Arm(s): LH in the luteal phase | Intervention Type: DRUG; Name: vaginal progesterone(Crinone; Merck-Serono, Hellerup, Denmark) and estradiol(Estrofem; Novo Nordisk, Copenhagen, Denmark) in the luteal phase; Assigned to Arm(s): vaginal progesterone and estradiol in the luteal phase
D: Arm Label: micronized progesterone; Type: EXPERIMENTAL; Interventions: Drug: micronized progesterone | Arm Label: no utrogestan; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: micronized progesterone; Assigned to Arm(s): micronized progesterone

Answer: D